Tempus AI surges 91.8% YTD with soaring genomics revenues and a $200M AstraZeneca deal, outpacing NVIDIA in AI healthcare gains.

The AI infrastructure leader has had a phenomenal run in recent years. The post Where Will Nvidia Be in 5 Years? appeared ...

An Entry Point to Growth & Income The S&P 500 has soared to new heights, driven largely by low-yielding tech giants, pushing ...

Explore Tesla, Inc.'s growth in robotaxis & robotics despite Q2 revenue dips. Click for my updated look at TSLA stock post ...

US stock market eyes pivotal breakout as a new U.S.–EU trade deal eases tariff tensions and lifts investor confidence at the ...

If Artificial General Intelligence becomes even partially realized over the next few years, the demand for NVDA ...

Nvidia and Palantir have delivered explosive gains over 1,000% in the past decade, while Microsoft offers stable long-term ...

ILCG offers cheap, efficient exposure to large-cap growth stocks, but current market greed and high valuations make growth ...

Nvidia and TSMC are two of the best ways to play the growth in AI infrastructure. Meta Platforms and Toast are using AI to ...

Justin Pope has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ASML, Alphabet, ...

In a sweeping move to reassert US dominance in artificial intelligence, President Donald Trump has unveiled America’s AI ...

Nvidia ( NVDA -0.12%) is considered a pioneer in the artificial intelligence (AI) hardware market, and rightly so, as the ...